Printer Friendly

Articles from M2 Pharma (April 3, 2019)

1-25 out of 25 article(s)
Title Author Type Words
Abattis to acquire European nutraceutical company Pro Natura. 256
Advaxis Inc to launch public offering of common stock. 155
Agenus doses first patient in clinical trial of anti-CTLA-4 antibody. 151
Akebia Therapeutics announces stock options at exercise price of USD8.19 per share under Nasdaq Listing Rule 5635(c)(4). 173
Amneal Names Pradeep Bhadauria as Chief Scientific Officer. 331
APR Applied Pharma Research unveils Diclofenac 50 mg powder oral solution for the treatment of migraine and other pain areas in Russia. 235
C3J Therapeutics Issued US Patent Covering Synthetic Bacteriophage. 427
CEL-SCI Reports Recent Data Review by the Independent Data Monitoring Committee for Its Pivotal Phase 3 Head and Neck Cancer Study. 429
Channel Medsystems awarded US FDA approval for Cerene Cryotherapy Device to treat heavy menstrual bleeding. 317
Coag-Sense wins US FDA approval for next generation PT/INR clot-detection monitoring system. 237
Dicerna Presents Updated Data Demonstrating Utility of its Lead Compound DCR-PHXC in Treating Primary Hyperoxaluria Type 1 and Type 2. 195
Emmes and NIH support study wins US FDA approval for first paediatric drug labelling change for 2019. 274
ENvizion wins US FDA 510(k) clearance for personalised feeding tube placement device. 279
ESTEVE names Thomas B. Riisager as chief corporate strategy & business development officer. 129
Ethicann Pharmaceuticals concludes initial financing round. 229
FDA Approves Tudorza Pressair (aclidinium bromide inhalation powder) Supplemental New Drug Application to include data for the Reduction of COPD Exacerbations and Hospitalizations. 453
JMP appoints David Schechner as managing director of healthcare investment banking group. 185
MiNA Therapeutics Presents Pre-Clinical Data Supporting Combination of MTL-CEBPA with Sorafenib and Other Cancer Treatments at AACR. 446
Novartis to acquire IFM Tre from IFM Therapeutics. 201
PredictImmune's First Prognostic Test for IBD, PredictSURE IBD, Launches in the UK and Ireland. 266
Puma Biotechnology signs license agreement with Pierre Fabre. 208
Sangamo, Pfizer Release Phase 1/2 Interim Data for Investigational Hemophilia A Gene Therapy. 702
Seres Therapeutics Presents New Preclinical Data Supporting the Development of SER-401 for Immuno-Oncology. 495
United States Food and Drug Administration grants breakthrough therapy designation to AstraZeneca and Merck's Selumetinib. 191
Xencor and Astellas Enter Collaboration for Novel Bispecific Antibody Program. 234

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters